Parent-Child Interaction Therapy for Disruptive Behaviors
(RAINBOW Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand and treat behavior problems in young children with tuberous sclerosis complex (TSC), a genetic disorder. It tests an internet-based therapy called Parent-Child Interaction Therapy (PCIT), which helps parents manage their children's challenging behaviors. Some children will start the therapy immediately, while others will begin after a 6-month delay, but all will eventually receive the same care. Children aged 3 to 6 years with TSC who face behavior challenges at home and have a parent available for therapy sessions might be a good fit for this study. As an unphased trial, this study offers families the chance to access innovative therapy that could significantly improve their child's behavior.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on behavioral therapy, so it's likely you can continue your medications, but you should confirm with the study team.
What prior data suggests that Parent-Child Interaction Therapy (PCIT) is safe for children with TSC?
Research shows that Parent-Child Interaction Therapy (PCIT) is generally safe and well-tolerated. Studies have demonstrated that PCIT effectively reduces challenging behaviors in children. For instance, one study reported significant improvements in children's behavior and a decrease in parenting stress. These positive results suggest that PCIT works well without needing major changes for different groups.
Additionally, PCIT has succeeded in various settings, including with children in foster care. This widespread success indicates its safety and effectiveness. While this study phase does not provide specific safety data, the use of PCIT with different groups supports its safety for children with behavior issues.12345Why are researchers excited about this trial?
Parent-Child Interaction Therapy (PCIT) is unique because it focuses on improving the parent-child relationship as a means to address disruptive behaviors. Unlike typical treatments that may rely on medication or individual therapy for the child, PCIT involves both the parent and child in real-time coaching sessions to enhance their communication and interaction skills. Researchers are excited about this approach because it empowers parents with effective tools and strategies to manage challenging behaviors, potentially leading to long-lasting positive changes in the family dynamic. This therapy not only targets the child's behavior but also strengthens the emotional bond between parent and child, which can be crucial for sustained behavioral improvement.
What evidence suggests that Parent-Child Interaction Therapy might be an effective treatment for behavior problems in children with TSC?
Studies have shown that Parent-Child Interaction Therapy (PCIT) reduces disruptive behaviors in children. Research indicates significant improvement in children's behavior problems, with parents noticing fewer issues after completing the therapy. One study found that all groups using PCIT experienced better child behavior and improved parenting skills. Another analysis showed that PCIT leads to important changes that last over time. In this trial, participants will either receive immediate PCIT treatment or be placed on a waitlist control, receiving PCIT after a delay. Although PCIT hasn't been specifically studied for children with tuberous sclerosis complex (TSC), its success with other disruptive behavior disorders suggests it could also help with TSC-related behavior issues.16789
Who Is on the Research Team?
Nicole McDonald, PhD
Principal Investigator
University of California, Los Angeles
Are You a Good Fit for This Trial?
This trial is for children aged 3-6 with tuberous sclerosis complex (TSC), both with and without behavior problems. To participate, kids must have a diagnosis of TSC. The study aims to help those struggling with disruptive behaviors by using internet-based therapy tailored for TSC families.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessments of developmental abilities and behavior problems using parent report measures and video recordings
Treatment
Internet-based Parent-Child Interaction Therapy (PCIT) sessions conducted weekly
Follow-up
Participants are monitored for safety and effectiveness after treatment, including play interactions, parent interviews, and questionnaires
What Are the Treatments Tested in This Trial?
Interventions
- Parent-Child Interaction Therapy (PCIT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor